Skip to content
Disclosery

EXANE DERIVATIVES: RSG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on RSG, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 1,909 RSG shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 1,909 shares
    Change vs previous 13F -156 shares

    0.14% of the 13F portfolio, value $249,800.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 2,065 shares
    Change vs previous 13F -399 shares

    0.08% of the 13F portfolio, value $273,614.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 2,464 shares
    Change vs previous 13F +500 shares

    0.08% of the 13F portfolio, value $343,616.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 1,964 shares
    Change vs previous 13F +284 shares

    0.06% of the 13F portfolio, value $235,806.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 1,680 shares
    Change vs previous 13F +1,393 shares

    0.04% of the 13F portfolio, value $189,188.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 287 shares
    Change vs previous 13F -794 shares

    0.01% of the 13F portfolio, value $28,515.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 1,081 shares
    Change vs previous 13F -288 shares

    0.03% of the 13F portfolio, value $104,104.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 1,369 shares
    Change vs previous 13F not available

    0.04% of the 13F portfolio, value $127,798.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).